![Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity : the Belgian experience Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity : the Belgian experience](https://biblio.ugent.be/publication/01GVZB2V55PGXR14NPF52MNEMT/file/01GVZB3VT34F6KY4FZ2TZ6WW3N/thumbnail.png)
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity : the Belgian experience
![NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol - ScienceDirect NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332222008770-ga1.jpg)
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol - ScienceDirect
![Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds | Bioanalysis Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds | Bioanalysis](https://www.future-science.com/cms/10.4155/bio-2015-0021/asset/images/medium/figure1.gif)
Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds | Bioanalysis
![Full article: Sativex® (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data Full article: Sativex® (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data](https://www.tandfonline.com/cms/asset/420468d5-5b29-4bb7-903e-e7369f901a59/iern_a_11212732_f0001_b.jpg)
Full article: Sativex® (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data
![Full article: Sativex® (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data Full article: Sativex® (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data](https://www.tandfonline.com/cms/asset/9b6a874e-05b8-443c-a0ac-a6f1b0d05ce8/iern_a_11212732_f0003_b.jpg)
Full article: Sativex® (tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data
![Thin-layer chromatography (TLC) of a sample of hashish (cannabis resin,... | Download Scientific Diagram Thin-layer chromatography (TLC) of a sample of hashish (cannabis resin,... | Download Scientific Diagram](https://www.researchgate.net/publication/327530480/figure/fig1/AS:679057888923648@1538911425032/Thin-layer-chromatography-TLC-of-a-sample-of-hashish-cannabis-resin-or-soapbar.png)
Thin-layer chromatography (TLC) of a sample of hashish (cannabis resin,... | Download Scientific Diagram
![Biomolecules | Free Full-Text | Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders Biomolecules | Free Full-Text | Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders](https://www.mdpi.com/biomolecules/biomolecules-10-00279/article_deploy/html/images/biomolecules-10-00279-g001.png)
Biomolecules | Free Full-Text | Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders
![A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01259-3/MediaObjects/41416_2021_1259_Fig1_HTML.png)
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma | British Journal of Cancer
![The man who secretly (and legally) grows 20 tonnes of cannabis a year | Pharmaceuticals industry | The Guardian The man who secretly (and legally) grows 20 tonnes of cannabis a year | Pharmaceuticals industry | The Guardian](https://i.guim.co.uk/img/static/sys-images/Observer/Columnist/Columnists/2011/4/14/1302800177910/Justin-Gover-007.jpg?width=465&dpr=1&s=none)
The man who secretly (and legally) grows 20 tonnes of cannabis a year | Pharmaceuticals industry | The Guardian
![Sativex Multiple Sclerosis Drug #5 iPhone 14 Case by Mark Thomas/science Photo Library - Science Photo Gallery Sativex Multiple Sclerosis Drug #5 iPhone 14 Case by Mark Thomas/science Photo Library - Science Photo Gallery](https://render.fineartamerica.com/images/rendered/default/phone-case/iphone14/images-medium-5/5-sativex-multiple-sclerosis-drug-mark-thomasscience-photo-library.jpg?&targetx=0&targety=-77&imagewidth=1797&imageheight=1197&modelwidth=1797&modelheight=1042&backgroundcolor=404040&orientation=1)
Sativex Multiple Sclerosis Drug #5 iPhone 14 Case by Mark Thomas/science Photo Library - Science Photo Gallery
![Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds | Bioanalysis Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds | Bioanalysis](https://www.future-science.com/cms/10.4155/bio-2015-0021/asset/images/medium/figure2.gif)
Techniques and technologies for the bioanalysis of Sativex®, metabolites and related compounds | Bioanalysis
![Study: Frequent Use of the Cannabis-Based Prescription Drug Associated with Opioid-Sparing Effects - NORML Study: Frequent Use of the Cannabis-Based Prescription Drug Associated with Opioid-Sparing Effects - NORML](https://i0.wp.com/norml.org/wp-content/uploads/2022/03/sativex-spray.jpg?fit=730%2C411&ssl=1)
Study: Frequent Use of the Cannabis-Based Prescription Drug Associated with Opioid-Sparing Effects - NORML
![Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience | BMC Neurology | Full Text Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience | BMC Neurology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12883-021-02246-0/MediaObjects/12883_2021_2246_Fig2_HTML.png)
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience | BMC Neurology | Full Text
![Full article: Can a previously co-designed device be used by others? A service evaluation of the use of the Sativex spray holder for individuals with multiple sclerosis Full article: Can a previously co-designed device be used by others? A service evaluation of the use of the Sativex spray holder for individuals with multiple sclerosis](https://www.tandfonline.com/cms/asset/8e3e5b19-9617-4a07-bca7-91ed1b7d0349/iidt_a_2228344_f0003_c.jpg)
Full article: Can a previously co-designed device be used by others? A service evaluation of the use of the Sativex spray holder for individuals with multiple sclerosis
Eczacının Not Defteri - Sativex Türkiye !!!!Türkiye'de medikal amaçlı esrar kullanımı sessiz sedasız yasallaştı.!!!! İlacın üretimi henüz Türkiye'de yapılmasa da kırmızı reçete ile yurt dışından getirip kullanımı mümkün hale getirildi. Yakın zamanda
![a) Effect of Sativex vs. placebo on rheumatoid arthritis sleep quality... | Download Scientific Diagram a) Effect of Sativex vs. placebo on rheumatoid arthritis sleep quality... | Download Scientific Diagram](https://www.researchgate.net/publication/6126756/figure/fig5/AS:277764411281435@1443235604632/a-Effect-of-Sativex-vs-placebo-on-rheumatoid-arthritis-sleep-quality-GWCRI016-N-14.png)